VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $21,723,000 | +7.0% | 121,778 | +33.3% | 4.80% | +6.5% |
| Q2 2015 | $20,297,000 | +10.5% | 91,368 | -1.2% | 4.50% | -1.4% |
| Q1 2015 | $18,374,000 | +30.3% | 92,510 | -6.1% | 4.57% | +9.5% |
| Q4 2014 | $14,106,000 | -22.4% | 98,570 | -28.9% | 4.17% | -23.5% |
| Q3 2014 | $18,185,000 | +65.5% | 138,610 | +59.0% | 5.45% | +32.3% |
| Q2 2014 | $10,990,000 | +37.6% | 87,160 | +43.8% | 4.12% | -5.0% |
| Q1 2014 | $7,989,000 | +36.5% | 60,600 | +21.6% | 4.33% | +15.7% |
| Q4 2013 | $5,852,000 | – | 49,850 | – | 3.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |